Keywords: strong, phase, ii, data, candidate, dengue, vacc

Strong Phase II data for candidate dengue vacc

Article | 24 September 2007

Print This

Acambis has welcomed data from French drug major Sanofi-Aventis' dengue vaccine candidate which is based on technology it licensed from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in